financetom
Business
financetom
/
Business
/
India's Zee should focus on cost cuts, struggling businesses in profit pursuit, panel says (March 26)
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India's Zee should focus on cost cuts, struggling businesses in profit pursuit, panel says (March 26)
Apr 3, 2024 7:39 AM

BENGALURU, March 26 (Reuters) - India's Zee

Entertainment should substantially reduce losses in its

businesses, including its English TV channels, and cut costs in

other areas to meet a key profit target, according to a

company-formed review panel, the broadcaster said Tuesday.

The move - coming on the heels of a failed $10 billion

merger with Sony India and the collapse of a $1.4

billion cricket broadcasting deal over a missed payment - is

aimed at helping the company hit key performance targets, Zee

said.

That includes a 20% earnings before interest, taxes,

depreciation, and amortisation (EBITDA) margin target proposed

by CEO Punit Goenka, Zee said. Its margin was 10.2% in the

December quarter.

Zee's business has struggled over the years, with

advertising revenue falling to $488 million for in 2022-23 from

around $600 million five years earlier. Cash reserves also

dropped about 25% in that period.

The committee - comprising company chairman R. Gopalan and

audit committee chairman Prakash Agarwal - has identified five

businesses, including its English television channels, the Hindi

channel 'Zindagi' and communication technology-maker Margo

Networks, where losses need to be substantially reduced, Zee

said.

Margo Networks lost 1.17 billion rupees in the year ended

March 31, 2023. Zee did not provide details on the performance

of the other businesses or respond to requests for comment.

The committee has also advised halving the costs at Zee's

technology and innovation centre in fiscal 2025, from the 6

billion rupees ($72 million) a year back, Zee said.

Zee, besides being locked in legal battles over the failed

Sony ( SONY ) and cricket deals, has to also contend with new competition

after Disney ( DIS ) and Reliance merged their Indian

media assets to create an $8.5 billion media behemoth.

($1 = 83.2670 Indian rupees)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer Unusual Options Activity For June 03
Pfizer Unusual Options Activity For June 03
Jun 3, 2024
Investors with a lot of money to spend have taken a bullish stance on Pfizer ( PFE ) . And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Update: Science Applications International Shares Fall After Lower Fiscal Q1 Adjusted Earnings, Revenue; Fiscal 2025 Guidance Reiterated
Update: Science Applications International Shares Fall After Lower Fiscal Q1 Adjusted Earnings, Revenue; Fiscal 2025 Guidance Reiterated
Jun 3, 2024
02:02 PM EDT, 06/03/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Science Applications International ( SAIC ) shares fell nearly 11% in recent Monday trading after reporting lower fiscal Q1 adjusted earnings and revenue. The company reported fiscal Q1 adjusted earnings of $1.92 per diluted share, down from $2.14 a year...
BMO Tweaks Dollarama Estimate Ahead of Q1, Says Near-Term Valuation Elevated
BMO Tweaks Dollarama Estimate Ahead of Q1, Says Near-Term Valuation Elevated
Jun 3, 2024
02:00 PM EDT, 06/03/2024 (MT Newswires) -- Dollarama ( DLMAF ) reports first quarter results on June 12 before market. BMO has lowered its first quarter SSS to 6% from 7% (Street 5.6%) after considering the possibility that more normalization may have occurred than previously assumed. EPS estimate is unchanged at $0.75 (in line with Street). According to analyst Tamy...
Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada
Optimi Health Up 12% After Reporting Drug Establishment License From Health Canada
Jun 3, 2024
02:07 PM EDT, 06/03/2024 (MT Newswires) -- Optimi Health ( OPTHF ) , a licensed psychedelics pharmaceutical manufacturer specializing in controlled substances, was last seen up 12% after the company on Monday said Health Canada awarded the company a Drug Establishment Licence to manufacture and sell its MDMA and psilocybin capsules. The designation affirmed a compliant rating for Good Manufacturing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved